Organon & Co.
OGNDrug Manufacturers - General
$13.84+0.22%As of Oct 30vs prior close
- Market cap
- $3.6B
- P/E (TTM)
- 17.3×
- P/E (FY1)
- 4.0×
- From 52W high
- 0.00%
- EPS (LTM)
- $0.77
- Revenue (LTM)
- $6.1B
- Net margin
- 3.49%
- Dividend yield
- 0.58%
Nomior Score
61
Steady ProfileSpeculativeTop 25% of the scored universe
Growth20
Quality63
Value88
Momentum73
Resilience42
Growth
−3.67%revenue a year over 6 fiscal years
YE19 $7.8BLTM $6.1B
Connections
Revenue to profitQ3 FY26
10% of revenue became net profit.
Who owns it
1fund, 1 tracked portfolio